Categories
Expert Witness History

Daewoong Pharma (S. Korea)

In the matter of certain Botulinum Toxin Products (ITC Inv. 337-TA-1145 2021) Sponsored public interest submission to ITC criticizing ALJ’s ruling that claimant’s bacteria is a trade secret. ITC reversed ALJ ruling.

Leave a Reply

Your email address will not be published.